TDP-43, an ALS Linked Protein, Regulates Fat Deposition and Glucose Homeostasis

PLoS ONE

Volumn 8, Issue 8, 2013, Pages

  Stallings, Nancy R ^a   Puttaparthi, Krishna ^a   Dowling, Katherine J ^a   Luther, Christina M ^a   Burns, Dennis K ^a   Davis, Kathryn ^a   Elliott, Jeffrey L ^a  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; GLUCOSE TRANSPORTER 4; INSULIN; PROTEIN TBC1D1; RAB PROTEIN; TAR DNA BINDING PROTEIN; UNCLASSIFIED DRUG;

ADIPOCYTE; ADIPOSE TISSUE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ISOLATION; CONTROLLED STUDY; DISEASE ASSOCIATION; FAT MASS; GENE OVEREXPRESSION; GLUCOSE HOMEOSTASIS; GLUCOSE TRANSPORT; IN VIVO STUDY; INSULIN RESPONSE; LEAN BODY WEIGHT; LIPID COMPOSITION; LIPID STORAGE; LIPOHYPERTROPHY; MALE; MOUSE; NONHUMAN; PHENOTYPE; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; SKELETAL MUSCLE; STEADY STATE; TDP 43 GENE; TISSUE DISTRIBUTION; TRANSGENIC MOUSE; WEIGHT GAIN;

ADIPOSE TISSUE; ADIPOSITY; ANIMALS; DNA-BINDING PROTEINS; GENE EXPRESSION; GLUCOSE; GLUCOSE TRANSPORTER TYPE 4; HOMEOSTASIS; HUMANS; INSULIN; MALE; MICE; MICE, TRANSGENIC; MUSCLE, SKELETAL; NUCLEAR PROTEINS; ORGAN SIZE; PROTEIN TRANSPORT;

EID: 84881533452     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0071793     Document Type: Article

References (42)

1. Kawahara Y, Mieda-Sato A, (2012) TDP-43 promotes microRNA biogenesis as a component of the Drosha and Dicer complexes. Proc Natl Acad Sci U.S.A. PubMed: 22323604.
2. Buratti E, Brindisi A, Giombi M, Tisminetzky S, Ayala YM, et al. (2005) TDP-43 binds heterogeneous nuclear ribonucleoprotein A/B through its C-terminal tail: an important region for the inhibition of cystic fibrosis transmembrane conductance regulator exon 9 splicing. J Biol Chem 280: 37572-37584. doi:10.1074/jbc.M505557200. PubMed: 16157593.
3. Bose JK, Wang IF, Hung L, Tarn WY, Shen CK, (2008) TDP-43 overexpression enhances exon 7 inclusion during the survival of motor neuron pre-mRNA splicing. J Biol Chem 283: 28852-28859. doi:10.1074/jbc.M805376200. PubMed: 18703504.
4. Kuo PH, Doudeva LG, Wang YT, Shen CK, Yuan HS, (2009) Structural insights into TDP-43 in nucleic-acid binding and domain interactions. Nucleic Acids Res 37: 1799-1808. doi:10.1093/nar/gkp013. PubMed: 19174564.
5. Ayala YM, De Conti L, Avendaño-Vázquez SE, Dhir A, Romano M, et al. (2011) TDP-43 regulates its mRNA levels through a negative feedback loop. EMBO J 30: 277-288. doi:10.1038/emboj.2010.310. PubMed: 21131904.
6. Polymenidou M, Lagier-Tourenne C, Hutt KR, Huelga SC, Moran J, et al. (2011) Long pre-mRNA depletion and RNA missplicing contribute to neuronal vulnerability from loss of TDP-43. Nat Neurosci 14: 459-468. doi:10.1038/nn.2779. PubMed: 21358643.
7. Neumann M, Sampathu DM, Kwong LK, Truax AC, Micsenyi MC, et al. (2006) Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science 314: 130-133. doi:10.1126/science.1134108. PubMed: 17023659.
8. Arai T, Hasegawa M, Akiyama H, Ikeda K, Nonaka T, et al. (2006) TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem Biophys Res Commun 351: 602-611. doi:10.1016/j.bbrc.2006.10.093. PubMed: 17084815.
9. Gitcho MA, Baloh RH, Chakraverty S, Mayo K, Norton JB, et al. (2008) TDP-43 A315T mutation in familial motor neuron disease. Ann Neurol 63: 535-538. doi:10.1002/ana.21344. PubMed: 18288693.
10. Rutherford NJ, Zhang YJ, Baker M, Gass JM, Finch NA, et al. (2008) Novel mutations in TARDBP (TDP-43) in patients with familial amyotrophic lateral sclerosis. PLOS Genet 4: e1000193. PubMed: 18802454.
11. Sreedharan J, Blair IP, Tripathi VB, Hu X, Vance C, et al. (2008) TDP-43 mutations in familial and sporadic amyotrophic lateral sclerosis. Science 319: 1668-1672. doi:10.1126/science.1154584. PubMed: 18309045.
12. Kabashi E, Valdmanis PN, Dion P, Spiegelman D, McConkey BJ, et al. (2008) TARDBP mutations in individuals with sporadic and familial amyotrophic lateral sclerosis. Nat Genet 40: 572-574. doi:10.1038/ng.132. PubMed: 18372902.
13. Stallings NR, Puttaparthi K, Luther CM, Burns DK, Elliott JL, (2010) Progressive motor weakness in transgenic mice expressing human TDP-43. Neurobiol Dis 40: 404-414. doi:10.1016/j.nbd.2010.06.017. PubMed: 20621187.
14. Wegorzewska I, Bell S, Cairns NJ, Miller TM, Baloh RH, (2009) TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration. Proc Natl Acad Sci U S A 106: 18809-18814. doi:10.1073/pnas.0908767106. PubMed: 19833869.
15. Wils H, Kleinberger G, Janssens J, Pereson S, Joris G, et al. (2010) TDP-43 transgenic mice develop spastic paralysis and neuronal inclusions characteristic of ALS and frontotemporal lobar degeneration. Proc Natl Acad Sci U S A 107: 3858-3863. doi:10.1073/pnas.0912417107. PubMed: 20133711.
16. Sephton CF, Good SK, Atkin S, Dewey CM, Mayer P 3rd, et al. (2010) TDP-43 is a developmentally regulated protein essential for early embryonic development. J Biol Chem 285: 6826-6834. doi:10.1074/jbc.M109.061846. PubMed: 20040602.
17. Kraemer BC, Schuck T, Wheeler JM, Robinson LC, Trojanowski JQ, et al. (2010) Loss of murine TDP-43 disrupts motor function and plays an essential role in embryogenesis. Acta Neuropathol 119: 409-419. doi:10.1007/s00401-010-0659-0. PubMed: 20198480.
18. Wu LS, Cheng WC, Hou SC, Yan YT, Jiang ST, et al. (2010) TDP-43, a Neuro-Pathosignature Factor, is Essential for Early Mouse Embryogenesis. Genesis 48: 56-62. PubMed: 20014337.
19. Chiang PM, Ling J, Jeong YH, Price DL, Aja SM, et al. (2010) Deletion of TDP-43 down-regulates Tbc1d1, a gene linked to obesity, and alters body fat metabolism. Proc Natl Acad Sci U S A 107: 16320-16324. doi:10.1073/pnas.1002176107. PubMed: 20660762.
20. Sakamoto K, Holman GD, (2008) Emerging role for AS160/TBC1D4 and TBC1D1 in the regulation of GLUT4 traffic. Am J Physiol Endocrinol Metab 295: E29-E37. doi:10.1152/ajpendo.90331.2008. PubMed: 18477703.
21. Meyre D, Farge M, Lecoeur C, Proenca C, Durand E, et al. (2008) R125W coding variant in TBC1D1 confers risk for familial obesity and contributes to linkage on chromosome 4p14 in the French population. Hum Mol Genet 17: 1798-1802. doi:10.1093/hmg/ddn070. PubMed: 18325908.
22. Sun K, Kusminski CM, Scherer PE, (2011) Adipose tissue remodeling and obesity. J Clin Invest 121: 2094-2101. doi:10.1172/JCI45887. PubMed: 21633177.
23. Fulcher FK, Smith BT, Russ M, Patel YM, (2008) Dual role for myosin II in GLUT4-mediated glucose uptake in 3T3-L1 adipocytes. Exp Cell Res 314: 3264-3274. doi:10.1016/j.yexcr.2008.08.007. PubMed: 18773891.
24. Lanner JT, Katz A, Tavi P, Sandström ME, Zhang SJ, et al. (2006) The role of Ca2+ influx for insulin-mediated glucose uptake in skeletal muscle. Diabetes 55: 2077-2083. doi:10.2337/db05-1613. PubMed: 16804078.
25. Puttaparthi K, Gitomer WL, Krishnan U, Son M, Rajendran B, et al. (2002) Disease progression in a transgenic model of familial amyotrophic lateral sclerosis is dependent on both neuronal and non-neuronal zinc binding proteins. J Neurosci 22: 8790-8796. PubMed: 12388585.
26. Chadt A, Leicht K, Deshmukh A, Jiang LQ, Scherneck S, et al. (2008) Tbc1d1 mutation in lean mouse strain confers leanness and protects from diet-induced obesity. Nat Genet 40: 1354-1359. doi:10.1038/ng.244. PubMed: 18931681.
27. Stone S, Abkevich V, Russell DL, Riley R, Timms K, et al. (2006) TBC1D1 is a candidate for a severe obesity gene and evidence for a gene/gene interaction in obesity predisposition. Hum Mol Genet 15: 2709-2720. doi:10.1093/hmg/ddl204. PubMed: 16893906.
28. Lansey MN, Walker NN, Hargett SR, Stevens JR, Keller SR, (2012) Deletion of Rab GAP AS160 modifies glucose uptake and GLUT4 translocation in primary skeletal muscles and adipocytes and impairs glucose homeostasis. Am J Physiol Endocrinol Metab 303: E1273-E1286. doi:10.1152/ajpendo.00316.2012. PubMed: 23011063.
29. Wang HY, Ducommun S, Quan C, Xie B, Li M, et al. (2012) AS160 deficiency causes whole-body insulin resistance via composite effects in multiple tissues. Biochem J, 449: 479-89. PubMed: 23078342.
30. Chen S, Wasserman DH, MacKintosh C, Sakamoto K, (2011) Mice with AS160/TBC1D4-Thr649Ala knockin mutation are glucose intolerant with reduced insulin sensitivity and altered GLUT4 trafficking. Cell Metab 13: 68-79. doi:10.1016/j.cmet.2010.12.005. PubMed: 21195350.
31. Marin B, Desport JC, Kajeu P, Jesus P, Nicolaud B, et al. (2011) Alteration of nutritional status at diagnosis is a prognostic factor for survival of amyotrophic lateral sclerosis patients. J Neurol Neurosurg, Psychiatry 82: 628-634. doi:10.1136/jnnp.2010.211474. PubMed: 21097551.
32. Dupuis L, Pradat PF, Ludolph AC, Loeffler JP, (2011) Energy metabolism in amyotrophic lateral sclerosis. Lancet Neurol 10: 75-82. doi:10.1016/S1474-4422(10)70224-6. PubMed: 21035400.
33. Bouteloup C, Desport JC, Clavelou P, Guy N, Derumeaux-Burel H, et al. (2009) Hypermetabolism in ALS patients: an early and persistent phenomenon. J Neurol 256: 1236-1242. doi:10.1007/s00415-009-5100-z. PubMed: 19306035.
34. Kasarskis EJ, Berryman S, Vanderleest JG, Schneider AR, McClain CJ, (1996) Nutritional status of patients with amyotrophic lateral sclerosis: relation to the proximity of death. Am J Clin Nutr 63: 130-137. PubMed: 8604660.
35. Nau KL, Bromberg MB, Forshew DA, Katch VL, (1995) Individuals with amyotrophic lateral sclerosis are in caloric balance despite losses in mass. J Neurol Sci 129 (Suppl):: 47-49. doi:10.1016/0022-510X(95)00061-6. PubMed: 7595619.
36. Pradat PF, Bruneteau G, Gordon PH, Dupuis L, Bonnefont-Rousselot D, et al. (2010) Impaired glucose tolerance in patients with amyotrophic lateral sclerosis. Amyotroph Lateral Scler 11: 166-171. doi:10.3109/17482960902822960. PubMed: 20184518.
37. Reyes ET, Perurena OH, Festoff BW, Jorgensen R, Moore WV, (1984) Insulin resistance in amyotrophic lateral sclerosis. J Neurol Sci 63: 317-324. doi:10.1016/0022-510X(84)90154-0. PubMed: 6374040.
38. Bingham NC, Anderson KK, Reuter AL, Stallings NR, Parker KL, (2008) Selective loss of leptin receptors in the ventromedial hypothalamic nucleus results in increased adiposity and a metabolic syndrome. Endocrinology 149: 2138-2148. doi:10.1210/en.2007-1200. PubMed: 18258679.
39. Tschop MH, Speakman JR, Arch JRS, Auwerx J, Bruning JC, et al. (2012) A guide to analysis of mouse energy metabolism. Nat Methods 9: 57-63.
40. Puttaparthi K, Elliott JL, (2005) Non-neuronal induction of immunoproteasome subunits in an ALS model: possible mediation by cytokines. Exp Neurol 196: 441-451. doi:10.1016/j.expneurol.2005.08.027. PubMed: 16242125.
41. Carlsen RC, Larson DB, Walsh DA, (1985) A fast-twitch oxidative-glycolytic muscle with a robust inward calcium current. Can J Physiol Pharmacol 63: 958-965. doi:10.1139/y85-158. PubMed: 2416421.
42. Malide D, Dwyer NK, Blanchette-Mackie EJ, Cushman SW, (1997) Immunocytochemical evidence that GLUT4 resides in a specialized translocation post-endosomal VAMP2-positive compartment in rat adipose cells in the absence of insulin. J Histochem Cytochem Off J Histochem Soc 45: 1083-1096. doi:10.1177/002215549704500806.